|
Closed
protocols, Scandinavian Scarcoma Group (SSG) |
|||
| SSG I | Adjuvant chemotherapy in STS | 1981-1986 | |
| SSG II | Combination therapy in OS | 1982-1990 | |
| SSG III | Radiotherapy in inoperable STS | 1982 | |
| SSG IV | Combined modality therapy in EWS | 1984-1990 | |
| SSG V | Treatment program for STS | 1986 | |
| SSG VI | Combined modality therapy for OS | 1987 | |
| SSG VIII | The treatment of OS | 1990-1998 | |
| SSG IX | Combined modality therapy in EWS | 1990-1999 | |
| SSG X | Treatment of advanced STS with (VIG) | 1991-1997 | |
| SSG XI | Palliative Oral Trofosfamide in the treatment of metastatic or locally advanced STS | 1994-1996 | |
| SSG XII | Metastasecetomy and chemotherapy for lungmetastases from STS. A randomized phase III study | 1996-2000 | |
| SSG XIII | Treatment protocol for adult patients with high-risk soft tissue sarcoma of the extremities and trunk wall | 1998-2007 | |
| SSG XIV | Treatment research protocol for extremity localized high-grade osteosarcoma. (Age < 41 years). | 2001-2005 | |
| SSG XV | Phase III randmized intergroup, international trial assessing the clinical activity of STI-571 at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors (GIST) expressing the KIT receptor tyrosine (CD117) | 2001 | |
| SSG XVIII | Short
(12 months) versus long (36 months) duration of adjuvant treatment
with the tyrosine kinase inhibitor imatinib mesylate of operable GIST
with a high risk for recurrence: A randomized phase III study. 2006
|
2004-2008 | |
| ISG/SSG I | An Italian - Scandinavian treatment and research protocol for high-grade osteosarcoma of the extremities (localized disease and metastatic relapse) | 1997-2000 | |
| ISG/SSG II | An Italian-Scandinavian treatment protocol for metastatic and pelvic osteosarcoma | 1998-2002 | |
| ISG/SSG IV | Treatment protocol for high-risk Ewing´s family tumors. | 1999-2009 | |